DE SARRO, Angelina
 Distribuzione geografica
Continente #
NA - Nord America 5.058
EU - Europa 4.151
AS - Asia 2.325
SA - Sud America 762
Continente sconosciuto - Info sul continente non disponibili 85
AF - Africa 75
OC - Oceania 4
Totale 12.460
Nazione #
US - Stati Uniti d'America 4.937
RU - Federazione Russa 1.980
SG - Singapore 994
BR - Brasile 660
CN - Cina 660
SE - Svezia 524
IE - Irlanda 511
UA - Ucraina 344
HK - Hong Kong 240
DE - Germania 234
VN - Vietnam 187
GB - Regno Unito 160
FI - Finlandia 121
FR - Francia 105
IN - India 66
IT - Italia 63
CA - Canada 50
AR - Argentina 33
BD - Bangladesh 26
MX - Messico 25
ZA - Sudafrica 23
JP - Giappone 21
TR - Turchia 21
EC - Ecuador 20
AT - Austria 19
BE - Belgio 17
PK - Pakistan 16
MA - Marocco 15
PL - Polonia 14
JO - Giordania 12
NL - Olanda 12
UZ - Uzbekistan 12
CL - Cile 10
CO - Colombia 10
ES - Italia 10
IQ - Iraq 10
AE - Emirati Arabi Uniti 9
VE - Venezuela 9
CZ - Repubblica Ceca 8
EG - Egitto 8
JM - Giamaica 8
PE - Perù 8
RS - Serbia 6
UY - Uruguay 6
CR - Costa Rica 5
ID - Indonesia 5
IL - Israele 5
MN - Mongolia 5
PY - Paraguay 5
TN - Tunisia 5
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EE - Estonia 4
GP - Guadalupe 4
IR - Iran 4
KE - Kenya 4
NI - Nicaragua 4
PA - Panama 4
PR - Porto Rico 4
SA - Arabia Saudita 4
SN - Senegal 4
GT - Guatemala 3
HN - Honduras 3
HU - Ungheria 3
KR - Corea 3
LB - Libano 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BW - Botswana 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PS - Palestinian Territory 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
ET - Etiopia 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
Totale 12.375
Città #
Jacksonville 676
Ashburn 657
Moscow 651
Singapore 554
Dublin 511
Dallas 491
Chandler 425
San Jose 294
Beijing 265
Nyköping 263
Hong Kong 238
Council Bluffs 169
Dong Ket 125
Princeton 105
Cambridge 104
Lauterbourg 92
The Dalles 92
Los Angeles 89
Boardman 84
Des Moines 79
Medford 76
Ann Arbor 65
Dearborn 51
Buffalo 50
Columbus 47
São Paulo 40
Woodbridge 37
Pune 29
New York 28
Tianjin 27
Wilmington 25
Guangzhou 24
Belo Horizonte 22
Ho Chi Minh City 22
Jinan 21
Orem 21
Phoenix 21
Rio de Janeiro 20
Houston 19
Lancaster 19
Redondo Beach 19
Shenyang 18
Vienna 18
Brussels 17
Brooklyn 16
Santa Clara 16
Montreal 15
Seattle 15
Frankfurt am Main 14
Hyderabad 14
London 14
Atlanta 12
Auburn Hills 12
Shenzhen 12
Tokyo 12
Warsaw 12
Chicago 11
Curitiba 11
Hangzhou 11
Hanoi 11
Hebei 11
Helsinki 11
Johannesburg 11
Munich 11
Washington 11
Amman 10
Amsterdam 10
Ningbo 10
Poplar 10
Porto Alegre 10
Saint Petersburg 10
San Mateo 10
Stockholm 10
Tashkent 10
Campinas 9
Milan 9
Monmouth Junction 9
Taizhou 9
Toronto 9
Zhengzhou 9
Denver 8
Miami 8
Morikitamachi 8
Norwalk 8
Quito 8
Rome 8
Salvador 8
San Francisco 8
Shanghai 8
Ankara 7
Brasília 7
Casablanca 7
Contagem 7
Las Vegas 7
Lima 7
Manchester 7
Mexico City 7
Nuremberg 7
Philadelphia 7
Turku 7
Totale 7.256
Nome #
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 314
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 269
5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein 261
5-AMINOISOQUINOLINONE REDUCES COLON INJURY BY EXPERIMENTAL COLITIS 244
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 225
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 217
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 211
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 205
Amoxicillin and amoxicillin plus clavulanate: a safety review 201
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 200
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates 189
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 180
Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica 173
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 169
Focus: Linguistic, cognitive, and computational perspectives 168
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 167
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method 166
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance 162
Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin 161
Amoxicillin and amoxicillin plus clavulanate: a safety review. 161
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 152
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 151
Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion 148
Amelioration of joint disease in a rat model of collagen- induced arthritis by M40403, a superoxide dismutase mimetic 143
Beneficial effects of n-acetylcysteine on ischaemic brain injury 141
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury 140
BENEFICIAL EFFECTS OF 5-AMINOISOQUINOLINONE, A NOVEL, POTENT, WATER-SOLUBLE, INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE, IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION 137
Geometric models in classical thermomechanics of continua with applications to irreversible phenomena 134
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 132
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 132
Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice 124
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 123
Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury 121
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 120
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 120
Protective effects of melatonin in ischemic brain injury 118
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 118
Effects of melatonin on ischemic brain injury 117
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice 114
Synthesis and pharmacological properties of new 3- ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines 112
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice 112
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 111
Synthesis and anticonvulsant activity of new 11H-triazolo[4,5- c] [2,3]benzodiazepines 108
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat 108
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 107
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 107
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 107
The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation 105
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan 105
Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats 104
Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase 104
Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 104
New and investigational antimicrobials for the treatment of severe skin infections 104
New and investigational triazole agents for the treatment of invasive fungal infections 104
RELATIONSHIP BETWEEN STRUCTURE AND CONVULSANT PROPERTIES OF SOME BETA-LACTAM ANTIBIOTICS FOLLOWING INTRACEREBROVENTRICULAR MICROINJECTION IN RATS 103
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. 102
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives 101
Linear hyperbolic systems of order-k in bounded and unbounded sets. Stability of complete controllability 101
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion 99
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice 99
Structure-activity relationships in thienodiazepine and benzodiazepine derivatives. 99
Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. 99
Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3- b]indol-3(3H)-ones in mice 97
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 97
Inducible nitric oxide synthase - Knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan 97
Convulsant effects of some xanthine: Derivatives in genetically epilepsy-prone rats 97
Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion 96
ERYTHROPOIETIN REDUCES THE DEVELOPMENT OF EXPERIMENTAL INFLAMMATORY BOWEL DISEASE 96
Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI) 96
Green tea polyphenol extract attenuates colon injury induced by experimental colitis 95
Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat 94
Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro- 1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives 93
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats 92
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 92
NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice 91
Role of IL-6 in the pleurisy and lung injury caused by carrageenan 91
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 90
Inducibile nitric oxide synthase knock out mice exhibit resistance to pleurisy lung injury caused by carrageenan 89
Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats 89
SYNTHESIS AND ANTICONVULSANT PROPERTIES OF 3-(1,3,4-THIADIAZOL- 2-YL)THIAZOLIDIN-4-ONES 89
Role of interleukin-6 in a non-septic shock model induced by zymosan 88
Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation 88
Synthesis and anticonvulsant activity of new 2,3- benzodiazepines as AMPA receptor antagonists 88
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 87
Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects 87
Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice 87
Role of interleukin-6 in a non septic shock model induced by zymosan 87
Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines. 86
The charta of milan: basic criteria for the appropriate and accurate use of antibiotics: recommendations of the italian society of chemotherapy. 86
WWW.ecm.farmacovigilanza.org: An Italian website for CME in pharmacovigilance 85
Role of interleukin-6 in splanchnic artery occlusion shock. 82
Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability 80
Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats 79
INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE MODULATE SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA. 79
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 78
Synthesis and anticonvulsant activity of novel non competitive as AMPA receptor antagonists. 77
Reversible orofacial dyskinesia after ofloxacin treatment 76
THALIDOMIDE TREATMENT REDUCES COLON INJURY INDUCED BY EXPERIMENTAL COLITIS 75
Interleukin-6 knock out mice exhibit a resistance to splanchnic artery occlusion shock 74
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 71
Totale 12.254
Categoria #
all - tutte 42.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.994


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022524 0 0 0 11 24 0 40 28 6 66 156 193
2022/20231.704 146 106 52 139 161 191 21 131 659 11 70 17
2023/2024466 52 70 27 108 25 84 12 47 1 16 4 20
2024/20251.750 20 18 58 113 101 35 9 477 449 59 111 300
2025/20264.639 161 303 455 310 423 1.189 532 504 485 157 69 51
2026/2027968 74 201 292 401 0 0 0 0 0 0 0 0
Totale 12.460